Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-01-19 @ 11:10 PM
Study NCT ID:
NCT01768195
Status:
UNKNOWN
Last Update Posted:
2017-01-10
First Post:
2013-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Sponsor:
Peking University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PKU-2012111304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None